HOME › DRUGS › SURUFATINIB
ACTIVE SUBSTANCE / INN

SURUFATINIB

Brand name(s): Sevsury
EMA LISTED
APPLICATION WITHDRAWN
Neuroendocrine Tumors
ACTIVE SUBSTANCE
Surufatinib
REGULATORS
EMA
SPONSORS / MAH
Hutchmed Europe B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SevsuryHutchmed Europe B.V.Application withdrawnNeuroendocrine Tumors

FULL INTELLIGENCE ON SURUFATINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →